Circulation ( IF 35.5 ) Pub Date : 2018-03-06 , DOI: 10.1161/circulationaha.117.031306 Kari L. Turkowski 1 , J. Martijn Bos 2, 3 , Nicholas C. Ackerman 3 , Ram K. Rohatgi 2 , Michael J. Ackerman 2, 3, 4
Until recently, expert guidelines such as the 2005 36th Bethesda Conference Guidelines1 and the 2005 European Society of Cardiology2 guidelines have recommended disqualification from most competitive sports for athletes with a variety of genetic heart diseases, aiming to prevent sudden cardiac death. However, recent studies have shown that carefully selected athletes with a variety of genetic heart diseases, including catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, who elected to continue in competitive sports after a shared decision-making evaluation rarely experienced disease-triggered breakthrough cardiac events.3–5 These observations have prompted acknowledgment of the importance of shared decision making and consideration of an athlete’s desire to return-to-play in the recent 2015 American Heart Association/American College of Cardiology scientific statement.5 This document recognized that the foundational evidence to compel a recommendation for disqualification was disease-dependent and, in many instances, lacking.5 It updated the Bethesda guidelines by defining return-to-play as an approval from an expert who specializes in genetic heart diseases to participate in competitive sports after a thorough examination and a comprehensive treatment/management plan has been established. Additionally, the statement advised disclosure of the athlete’s medical condition to the athlete’s school/university with no guarantee that the host institution will uphold the return-to-play decision.5
After approval by the Mayo Clinic Institutional Review Board, a …
中文翻译:
患有遗传性心脏病的运动员的重返比赛
直到最近,专家指南(例如2005年第36届Bethesda会议指南1和2005年欧洲心脏病学会2指南)都建议取消具有多种遗传性心脏病的运动员的大多数竞技运动资格,以防止心脏猝死。然而,最近的研究表明,精心挑选的患有多种遗传性心脏病的运动员,包括儿茶酚胺能性多形性室性心动过速和长QT综合征,他们经过共同的决策评估后选择继续参加竞技运动,很少遇到因疾病引起的突破性心脏事件。3 – 5这些发现促使人们在最近的2015年美国心脏协会/美国心脏病学会的科学声明中认识到共同决策的重要性,并考虑了运动员重返比赛的愿望。5该文件认识到,强制取消资格推荐的基础证据取决于疾病,在许多情况下是缺乏的。5它对Bethesda指南进行了更新,将重返赛程定义为经过全面检查并制定了全面的治疗/管理计划后,获得遗传心脏病专科医生参加竞技运动的认可。此外,该声明还建议向运动员的学校/大学披露运动员的健康状况,但不能保证主办机构会坚持比赛的决定。5
经过梅奥诊所机构审查委员会的批准,…